| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.12 | 4e-05 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | 0.13 | 4e-05 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | 0.16 | 5e-05 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.14 | 8e-05 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | 0.15 | 8e-05 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.0001 |